Craig A. Barbarosh - 09 Nov 2023 Form 4 Insider Report for NEXTGEN HEALTHCARE, INC.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Nov 2023, 16:38:01 UTC
Prior SEC filing
05 Sep 2023
Next SEC filing
04 Dec 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jeffrey D. Linton, Attorney-in-Fact for Craig A. Barbarosh

Key filing fact

Craig A. Barbarosh filed Form 4 for NEXTGEN HEALTHCARE, INC. on 13 Nov 2023.

Key facts

  • This page summarizes Craig A. Barbarosh's Form 4 filing for NEXTGEN HEALTHCARE, INC..
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 13 Nov 2023, 16:38.

Change

  • Previous filing in this sequence was filed on 05 Sep 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NXGN transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-67,269
Change %
-100%
Price
Shares after
0
Date
09 Nov 2023
Ownership
See footnotes
Footnotes
F1, F2, F3, F4, F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NXGN transaction Derivative

Deferred Stock Units

Disposed to Issuer

Transaction value
Shares
-9,483
Change %
-100%
Price
Shares after
0
Date
09 Nov 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,483
Exercise price
Footnotes
F2, F3, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Includes 10,086 outstanding vested shares of restricted stock.

Footnote F2

Pursuant to the Agreement and Plan of Merger, dated September 5, 2023, by and among the Issuer, Next Holdco Co., LLC ("Next Holdco") and Next Merger Sub, Inc. ("Merger Sub"), the Issuer became a wholly owned subsidiary of Next Holdco upon consummation of the merger with Merger Sub on November 9, 2023 (the "Effective Time"). At the Effective Time: (a) each of the Issuer's outstanding shares of common stock, each outstanding restricted stock unit and each outstanding deferred stock unit was cancelled and automatically converted into the right to receive $23.95 in cash; (b) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was cancelled and converted into the right to receive $23.95 in cash less the applicable per share exercise price; and (c) each of the Issuer's outstanding performance stock units was cancelled and converted into the right to receive $23.95 (with respect to the Issuer shares underlying the portion of such award which had

Footnote F3

(Continued from footnote 2) vested), and, with respect to any portion of such award the vesting of which remained subject to achievement of performance objectives as of October 4, 2023, $23.95 for each Issuer share underlying the portion of the award that would vest as a result of the Merger in accordance with the terms and conditions of the applicable award agreement, which for the units granted in 2020 assumed performance achievement at the "maximum" level; for the units granted in 2021, assumed performance achievement above "target" with partial achievement of the next stock price hurdle; and for the units granted in 2022, assumed performance achievement at 140% of the "target" level.

Footnote F4

The ownership form includes both direct and indirect holdings.

Footnote F5

Indirect ownership includes the holdings of the The Barbarosh Family Trust established May 29, 2007.

Footnote F6

The Deferred Stock Units credited under the Deferred Compensation Plan are generally payable in the form elected or provided under the Deferred Compensation Plan on the earlier of (i) the date or event elected by the reporting person, (ii) within 90 days following the participant's separation from service as defined under the Deferred Compensation Plan, or (ii) upon death, disability or change in control as defined under the Deferred Compensation Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .